Shanghai, China – June 25, 2026 — MicroPort® MedBot™ announced the successful completion of a cross-border robot-assisted telesurgical procedure connecting China and Thailand from the company's Global Telesurgery Command Center in Shanghai.

During the procedure, three Thai urologists jointly operated the Toumai® surgical robotic system from Shanghai to perform a robot-assisted radical prostatectomy on a patient located approximately 3,000 kilometres away in Thailand.

The procedure follows the Toumai® system's CE MDR certification for robot-assisted telesurgery announced on June 17, 2026, and further expands the company's international telesurgery programme.

Unlike domestic remote procedures, cross-border telesurgery requires secure transmission of clinical data across multiple telecommunications networks and jurisdictions, presenting additional technical and operational challenges. The Toumai® system supports a range of communication infrastructures—including 5G, broadband internet, dedicated fibre networks, and satellite communications—through low-latency transmission, multi-network integration, and secure data communication designed to support robotic-assisted telesurgery across diverse healthcare environments.

To date, the Toumai® surgical robotic system has supported more than 1,200 robot-assisted telesurgical procedures worldwide, connecting surgical teams across Asia, Europe, North America, South America, and Africa. Toumai® has also surpassed 300 global commercial orders and has been installed in more than 60 countries and regions.

This latest procedure further strengthens Toumai®'s telesurgery activities in Southeast Asia and highlights the growing role of robotic-assisted surgery in supporting international clinical collaboration, surgical education, and improved access to specialist expertise across borders.

About MicroPort® MedBot™

Commenced development of laparoscopic surgical robots in 2014 and officially established in Shanghai in 2015, Shanghai MicroPort MedBot (Group) Co., Ltd. ("MicroPort® MedBot™", stock code: 02252.HK), a subsidiary of MicroPort Scientific Corporation ("MicroPort®", stock code: 00853.HK), is currently the only surgical robotics company with businesses spanning five major segments: laparoscopic, orthopedic, vascular interventional, natural orifice, and percutaneous surgical robotics.

MicroPort® MedBot™ integrates robotics, intelligent control, image-guided navigation, and precision imaging technologies to develop intelligent surgical solutions that support minimally invasive care worldwide.

Regulatory Disclaimer

The Toumai® surgical robotic system's regulatory approvals and cleared indications vary by country and region. Not all indications or uses described in this release may be approved in all markets. Healthcare professionals should refer to applicable local regulatory requirements and the product instructions for use.

References

Global telesurgery procedural volume and commercial installation data – Data on file, MicroPort® MedBot™.